Every step we take ….

MRX1 is being dosed in a clinical trial as we speak 🥇🚀💪👌👍

💪👌

I listened to Ray Dalio being interviewed. Thought I’d buy a gold ETF and some Bitcoin exposure. Almost impossible in my SIPP. Any pointers welcome!

Execution.

Taking care of business.

Meet the team: Jeremy leads finance, PR, and strategy at Ananda. #BiotechLeadership #ExecutiveTeam #FinanceAndStrategy Melissa Sturgess

Worth a few minutes of your life

Well this happened faster than we expected. Trump says CBD to be reimbursed in the US, doctors trained and FDA will need an “approvable” formulation. Which is our MRX1. ✔️✔️ Ananda Pharma Plc

Yes.

I am if you're the alternative.

If you are interested in joining us on our journey it’s easy! DM me if you have any questions.

#TET As widely expected Natara have had to increase their proposed bid for Treatt It’s now 290p cash Previously they offered 260p The shares closed at 273p on Friday so this was anticipated Mind you with only 4.21% acceptances it certainly doesn’t look at all a done deal 🙄

#QTX Andy keeps delivering👏🏼 Strong Q3 raises guidance again so that’s an exceed the exceeded expectations🙃 Cash nicely up £4.3m “Accelerated growth in ARR, reduced manufacturing cost and continued emphasis on overhead efficiency have led to a further improvement in the outlook”

50% of our PK study participants are women. You’d think that would be a no brainer (but assume nothing and you will go far).

Great to see a significant shareholder joining the Board. #goldbull #gold #goldstocks

I’ve got to know Mark over the past couple of yrs. Huge stock broking & emerging markets experience. A big shareholder. A great addition to the Lexington Gold Ltd Board. Lexington Gold's new high profile NED says it's all about the ounces, ou... youtu.be/k64xeEagrxo?si… via YouTube

Finance Director Jeremy Sturgess-Smith toured the SGS facility in Deeside, where MRX1 is made. Holding a finished bottle was a surreal moment, bringing years of work at Ananda to life. Head over to our InvestorHub through the link in our bio to watch the video. #CBD #Biotech

Excellent book on AI and how it might play out. Def worth reading, especially if you are an investor and wondering what the future might hold for AI-exposed companies. Written by a co founder of Deepmind so not a rubbish viewpoint although he obviously has a vested interest 🤓

We’re featured in MJBizDaily: “How a woman-led biotech firm is advancing cannabis medicine.” CEO Melissa Sturgess will be at MJBizCon this December ahead of that, read about how pharma-grade cannabinoid research can change women’s health. Read more: mjbizdaily.com/ananda-pharma/